ATE305785T1 - Cd45 hemmer - Google Patents

Cd45 hemmer

Info

Publication number
ATE305785T1
ATE305785T1 AT00985615T AT00985615T ATE305785T1 AT E305785 T1 ATE305785 T1 AT E305785T1 AT 00985615 T AT00985615 T AT 00985615T AT 00985615 T AT00985615 T AT 00985615T AT E305785 T1 ATE305785 T1 AT E305785T1
Authority
AT
Austria
Prior art keywords
inhibitors
compositions
cell
treatment
disclosed
Prior art date
Application number
AT00985615T
Other languages
English (en)
Inventor
Marc Jerome Chapdelaine
Katherine Knappenberger
Gary Steelman
Suzanne Suchard
Linda Sygowski
Rebecca Urbanek
Chris Allan Veale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE305785T1 publication Critical patent/ATE305785T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Amplifiers (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
AT00985615T 1999-12-21 2000-12-18 Cd45 hemmer ATE305785T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17278599P 1999-12-21 1999-12-21
PCT/GB2000/004867 WO2001045680A2 (en) 1999-12-21 2000-12-18 Cd45 inhibitors

Publications (1)

Publication Number Publication Date
ATE305785T1 true ATE305785T1 (de) 2005-10-15

Family

ID=22629228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00985615T ATE305785T1 (de) 1999-12-21 2000-12-18 Cd45 hemmer

Country Status (7)

Country Link
US (1) US20030130298A1 (de)
EP (1) EP1242086B1 (de)
JP (1) JP2003518039A (de)
AT (1) ATE305785T1 (de)
AU (1) AU2202301A (de)
DE (1) DE60023034T2 (de)
WO (1) WO2001045680A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2834289B1 (fr) * 2001-12-27 2004-03-19 Sod Conseils Rech Applic Derives de benzothiazole-4,7-diones et benzooxazole-4,7- diones, leur preparation et leurs applications therapeutiques
CN100425600C (zh) * 2001-12-27 2008-10-15 科学研究和应用咨询公司 苯并噻唑－和苯并唑－4,7－二酮衍生物及其作为cdc25磷酸酯酶抑制剂的用途
JP2006151810A (ja) * 2002-12-26 2006-06-15 Daiichi Asubio Pharma Co Ltd ジヒドロチエノキノリン誘導体及びそれを含む細胞接着阻害剤
FR2877667B1 (fr) 2004-11-05 2007-03-23 Sod Conseils Rech Applic Derives de 4,7-dioxobenzothiazole-2-carboxamides, leur preparation et leurs applications therapeutiques
FR2879598B1 (fr) 2004-12-17 2007-03-30 Sod Conseils Rech Applic Inhibiteurs de phosphatases cdc25

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3243444A (en) * 1962-06-27 1966-03-29 Jr Arthur Sweeny Manufacture of fluorine derivatives of phenanthrenequinone
JPS60149603A (ja) * 1984-01-17 1985-08-07 Kuraray Co Ltd 光重合性の組成物
HU196288B (en) * 1985-06-04 1988-11-28 Egyt Gyogyszervegyeszeti Gyar Fungicides containing as active substance new derivatives of fenantren and process for production of the active substance
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds

Also Published As

Publication number Publication date
JP2003518039A (ja) 2003-06-03
AU2202301A (en) 2001-07-03
US20030130298A1 (en) 2003-07-10
EP1242086A2 (de) 2002-09-25
WO2001045680A2 (en) 2001-06-28
DE60023034D1 (en) 2006-02-16
EP1242086B1 (de) 2005-10-05
DE60023034T2 (de) 2006-07-13
WO2001045680A3 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
YU21401A (sh) Tetrahidropiridoetri
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
NO20032254L (no) Forbindelser for inhibering av ekspresjon av VACM-I
DE60214703D1 (de) Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
AU2002213336A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
ATE401314T1 (de) Benzodiazepin-derivate als gamma-secretase inhibitoren
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
ATE400577T1 (de) Anellierte dihydropyrane
ATE355288T1 (de) Verbindungen und therapeutische methoden
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
DE60042401D1 (de) Fab-i inhibitoren
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
SE0003476D0 (sv) Compounds
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
DK1189627T3 (da) Sammensætninger indeholdende opløselige former af HLA-G til behandling af inflammatoriske patologiske tilstande i huden
TR200200278T2 (tr) Kalsilitik bileşimler
ATE305785T1 (de) Cd45 hemmer
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
NO20005548D0 (no) Mykobakterieinhibitorer
DK1244614T3 (da) Tryptase-inhibitorer
NO20055517L (no) 4-,6-O 7-hydroksyindoler med N-oksidgrupper og anvendelse av disse som terapeutiske midler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties